Twist Bioscience

$137.81
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$3.20 (+2.38%) Today
+$0.17 (+0.12%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell TWST and other stocks, options, and ETFs commission-free!

About TWST

Twist Bioscience Corp. develops proprietary semiconductor-based synthetic DNA manufacturing process. It produces synthetic biology tools such as genes, oligo pools, variant libraries, DNA data storage and NGS. The firm also produces agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. The company was founded by William Marine Banyai, Emily Marine Leproust and Bill James Peck in February 2013 and is headquartered in San Francisco, CA. The listed name for TWST is Twist Bioscience Corporation Common Stock.

CEO
Emily Marine Leproust
Employees
525
Headquarters
San Francisco, California
Founded
2013
Market Cap
6.74B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.03M
High Today
$140.47
Low Today
$125.99
Open Price
$134.71
Volume
883.24K
52 Week High
$214.07
52 Week Low
$18.52

TWST News

BenzingaFeb 24

Twist Bioscience Launches Methylation Detection Systems

Twist Bioscience Corp (NASDAQ: TWST) has launched its NGS Methylation Detection System, end-to-end sample preparation, and target enrichment solution for identi

TWST Earnings

-$1.00
-$0.67
-$0.33
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected May 6, After Hours

You May Also Like

DY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure